EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Reprogrammed Lipid Metabolism-Associated Therapeutic Vulnerabilities in Prostate Cancer

Prashanth Parupathi iD, Lakshmi Sirisha Devarakonda iD, Ekniel Francois, Mehak Amjed, Avinash Kumar iD

International Journal of Molecular Sciences · 18.09.2025 · 26 (18) · 9132

DOI: 10.3390/ijms26189132 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.09.2025. Verfasst von Prashanth Parupathi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutical Sciences, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY 11201, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Lipid Metabolism. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa), the second leading cause of cancer-related mortality among men in the United States, is marked by profound metabolic reprogramming, particularly in lipid metabolism. This review highlights the pivotal role of altered lipid metabolic pathways, including de novo fatty acid synthesis, fatty acid uptake and transport, β-oxidation, and cholesterol metabolism, in the development, progression, and therapeutic resistance of PCa. Key enzymes and transcription factors, such as FASN, ACLY, SREBPs, and FABPs, which are mainly regulated by androgen receptor signaling, orchestrate a lipogenic phenotype that supports prostate tumor growth and survival. Crosstalk between lipid metabolism and the tumor microenvironment further promotes immune evasion and metastasis. The review also explores therapeutic opportunities in targeting lipid metabolic pathways, highlighting the preclinical and clinical advances in inhibiting FASN, SREBP1, SREBP2, HMGCR, and FABPs, as well as combinatorial strategies with conventional therapies. Understanding the impact of lipid metabolism on PCa pathogenesis provides a promising avenue for developing novel targeted and combinatorial interventions to improve clinical outcomes in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsLipid MetabolismHumansMaleAnimalsTumor MicroenvironmentSignal Transduction

Stichwörter der Autor:innen

cholesterol metabolismfatty acid metabolismlipid metabolismprostate cancerprostate cancer therapy

Autor:innen und Institutionen

  • Division of Pharmaceutical Sciences, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY 11201, USA.

ORCID-Profile: Prashanth Parupathi, Lakshmi Sirisha Devarakonda, Avinash Kumar

Zitieren

APA

Parupathi, P., Devarakonda, L. S., Francois, E., Amjed, M., & Kumar, A. (2025). Reprogrammed Lipid Metabolism-Associated Therapeutic Vulnerabilities in Prostate Cancer. International Journal of Molecular Sciences, 26(18), 9132. https://doi.org/10.3390/ijms26189132

Vancouver

Parupathi P, Devarakonda LS, Francois E, Amjed M, Kumar A. Reprogrammed Lipid Metabolism-Associated Therapeutic Vulnerabilities in Prostate Cancer. International Journal of Molecular Sciences. 2025;26(18):9132. doi:10.3390/ijms26189132

BibTeX
@article{Parupathi2025,
  author = {Parupathi, Prashanth and Devarakonda, Lakshmi Sirisha and Francois, Ekniel and Amjed, Mehak and Kumar, Avinash},
  title = {Reprogrammed Lipid Metabolism-Associated Therapeutic Vulnerabilities in Prostate Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {18},
  pages = {9132},
  doi = {10.3390/ijms26189132}
}
Kostenlos starten →